Prevalence of insomnia and use of sleep aids among adults in Canada
Open Access
- 30 September 2024
- journal article
- research article
- Published by Elsevier in Sleep Medicine
- Vol. 124, 338-345
Abstract
No abstract availableKeywords
Funding Information
- Canadian Institutes of Health Research (182032, 182034, 148410)
- Boehringer Ingelheim
- Natural Sciences and Engineering Research Council of Canada
- Wellcome Trust
This publication has 24 references indexed in Scilit:
- Examining sleep characteristics in Canada through a diversity and equity lensSleep Health, 2024
- World sleep society international sleep medicine guidelines position statement endorsement of “behavioral and psychological treatments for chronic insomnia disorder in adults: An American Academy of sleep medicine clinical practice guidelines”Sleep Medicine, 2023
- A systematic review and meta-analysis of the association between young adults’ sleep habits and substance use, with a focus on self-medication behavioursSleep Medicine Reviews, 2023
- Gender differences in the prevalence of and trends in sleep patterns and prescription medications for insomnia among US adults, 2005 to 2018Sleep Health, 2022
- Epidemiology of InsomniaSleep Medicine Clinics, 2022
- The association of insomnia disorder characterised by objective short sleep duration with hypertension, diabetes and body mass index: A systematic review and meta-analysisSleep Medicine Reviews, 2021
- A decade's difference: 10-year change in insomnia symptom prevalence in Canada depends on sociodemographics and health statusSleep Health, 2018
- The use of natural products for sleep: A common practice?Sleep Medicine, 2009
- Insomnia and its relationship to health-care utilization, work absenteeism, productivity and accidentsSleep Medicine, 2009
- Psychological and health-related quality of life factors associated with insomnia in a population-based sampleJournal of Psychosomatic Research, 2007